تداخل‌های دارویی
Arformoterol + Indacaterol-glycopyrronium
شدت: شدید
Arformoterol and Indacaterol-glycopyrronium: major interaction.
آخرین به‌روزرسانی
ویژه کادر درمان — فقط جهت مرجع. این صفحه خلاصه‌ای کوتاه است، توصیه پزشکی نیست و جایگزین بروشور رسمی یا قضاوت بالینی نمی‌شود. پیش از تجویز یا تحویل دارو همیشه بررسی کنید.
محتوای بالینی این صفحه فقط به زبان انگلیسی موجود است.
خلاصه
Both agents are inhaled long-acting beta-2 agonists (indacaterol is one component of the combination), so using them together duplicates therapy and adds to beta-adrenergic cardiovascular effects. This can cause tachycardia, hypokalemia, QTc prolongation and arrhythmia.
معنای این تداخل به زبان ساده
Arformoterol and Indacaterol-glycopyrronium can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for.
Arformoterol belongs to Respiratory; Indacaterol-glycopyrronium belongs to Respiratory.
چرا رخ می‌دهد
Additive beta-2 adrenergic stimulation leading to hypokalemia, tachycardia and QT prolongation.
اقدام لازم
Avoid concurrent use of two long-acting beta-agonists and keep a single LABA-containing regimen. If a switch is made, stop one agent and monitor heart rate, potassium and ECG as indicated.
از داروساز چه بپرسید
- Does the benefit of taking both outweigh the risk in my case?
- Do I need any blood test, ECG or other check while on both?
- What early warning signs should I watch for, and what should I do if they appear?
ویژه اعضای Pro+
باز کردن کل صفحه
یک حساب بسازید و دوره آزمایشی Pro+ را شروع کنید تا توصیه‌های کامل مدیریت Arformoterol و Indacaterol-glycopyrronium، یادداشت‌های تکمیلی، جزئیات شواهد و بررسی‌کننده تداخل برای کل نسخه را باز کنید.
- Full clinical management advice
- Additional notes
- Evidence detail
- Interaction checker for a whole prescription
Pro+ را ۱۴ روز رایگان در وب امتحان کنید. بدون نیاز به کارت.
تداخلات دیگر Indacaterol-glycopyrronium
تداخلات دیگر Arformoterol
پرسش‌های متداول
Can I take Arformoterol with Indacaterol-glycopyrronium?
MediHelp rates the interaction as major. Arformoterol and Indacaterol-glycopyrronium can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for. Both agents are inhaled long-acting beta-2 agonists (indacaterol is one component of the combination), so using them together duplicates therapy and adds to beta-adrenergic cardiovascular effects. This can cause tachycardia, hypokalemia, QTc prolongation and arrhythmia.
How serious is the interaction between Arformoterol and Indacaterol-glycopyrronium?
MediHelp rates it major, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Avoid concurrent use of two long-acting beta-agonists and keep a single LABA-containing regimen. If a switch is made, stop one agent and monitor heart rate, potassium and ECG as indicated.
What other medicines interact with Indacaterol-glycopyrronium?
MediHelp also lists interactions of Indacaterol-glycopyrronium with, for example, Amisulpride, Arsenic trioxide, Betaxolol. The full list is on the Indacaterol-glycopyrronium page.
تک‌نگاری کامل، دوزاژ و بررسی تداخل دارویی در برنامه MediHelp
مرجع کامل را باز کنید، تداخل چند دارو را بررسی کنید و از ابزارهای دوز در برنامه MediHelp استفاده کنید.
